The price of innovation - the role of drug pricing in financing pharmaceutical innovation. A conceptual framework-Reference-Cited by-同舟云学术

The price of innovation - the role of drug pricing in financing pharmaceutical innovation. A conceptual framework

Published:2019-01-01 Issue:1 Volume:7 Page:1583536
ISSN:2001-6689
Container-title:Journal of Market Access & Health Policy
language:en
Short-container-title:Journal of Market Access & Health Policy

Author:

Moreno Santiago G.¹,Epstein David²^ORCID

Affiliation:

1. Department of Market Access & Public Affairs, Novartis Pharma AG., Basel, Switzerland

2. Department of Applied Economics, University of Granada, Campus de Cartuja, Granada, Spain

Funder

no funding

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/20016689.2019.1583536

Reference61 articles.

1. Cockburn IM, Henderson RM, School MS, et al. Balancing incentives in pharmaceutical research; 2004. Available from: http://www.mit.edu/people/rhenders/WorkingPapers/CHS_Balance_01_04_V4.pdf

2. EFPIA. EFPIA response to draft opinion on innovative payment models for high-cost innovative medicines; 2017a. Available from: https://www.efpia.eu/media/288630/final_efpia-response-to-exph-draft-opinion-7_12_2017_wir.pdf

3. EFPIA. Healthier future the case for outcomes-based, sustainable healthcare; 2017b. Available from: https://www.efpia.eu/media/412313/the-case-for-outcomes-document-17102018.pdf

4. Hill S, Velazquez A, Tay-Teo K, et al. 2015 Global survey on health technology assessment by national authorities. Geneva; 2015. Available from: www.who.int

5. Wenzl M, Paris V. Phamaceutical reimbursement and pricing in Germany; 2018. Available from: http://www.oecd.org/els/health-systems/Pharmaceutical-Reimbursement-and-Pricing-in-Germany.pdf

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dissolution kinetics of propranolol hydrochloride 40 mg tablets under biowaiver conditions;Journal of Pharmacy & Pharmacognosy Research;2024-09-01

2. POSSIBLE SOLUTION FOR THE GLOBAL PROBLEM OF THE HIGH COST OF MEDICINES;Proceeding of the Shevchenko Scientific Society. Medical Sciences;2024-06-19

3. A Framework for the Fair Pricing of Medicines;PharmacoEconomics;2023-12-08

4. [Translated article] Risk-sharing agreement based on health outcomes for the treatment of moderate–severe psoriasis with certolizumab pegol;Farmacia Hospitalaria;2023-12

5. Acuerdo de riesgo compartido basado en resultados de salud para el tratamiento de psoriasis moderada-grave con certolizumab pegol;Farmacia Hospitalaria;2023-09